Methyl-CpG Binding Protein 2 Regulates Microglia and Macrophage Gene Expression in Response to Inflammatory Stimuli

Immunity

Volumn 42, Issue 4, 2015, Pages 679-691

  Cronk, James C ^a   Derecki, Noël C ^a   Ji, Emily ^a   Xu, Yang ^c   Lampano, Aaron E ^c   Smirnov, Igor ^a   Baker, Wendy ^a   Norris, Geoffrey T ^a   Marin, Ioana ^a   Coddington, Nathan ^a   Wolf, Yochai ^d   Turner, Stephen D ^a   Aderem, Alan ^e   Klibanov, Alexander L ^a,b   Harris, Tajie H ^a   Jung, Steffen ^d   Litvak, Vladimir ^c   Kipnis, Jonathan ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b University of Virginia   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; TAMOXIFEN; CHEMOKINE RECEPTOR; CRE RECOMBINASE; CX3CR1 PROTEIN, MOUSE; INTEGRASE; MECP2 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MALE; MICROGLIA; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETT SYNDROME; ANIMAL; C57BL MOUSE; CPG ISLAND; DEFICIENCY; DISEASE MODEL; DNA METHYLATION; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETICS; HIGH THROUGHPUT SEQUENCING; HOMEOSTASIS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LONGEVITY; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CPG ISLANDS; DISEASE MODELS, ANIMAL; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOMEOSTASIS; HUMANS; INTEGRASES; LONGEVITY; MACROPHAGES, PERITONEAL; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; RECEPTORS, CHEMOKINE; RETT SYNDROME; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84928175766     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.03.013     Document Type: Article

References (44)

1. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23:185-188.
2. Bain C.C., Scott C.L., Uronen-Hansson H., Gudjonsson S., Jansson O., Grip O., Guilliams M., Malissen B., Agace W.W., Mowat A.M. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 2013, 6:498-510.
3. Ballas N., Lioy D.T., Grunseich C., Mandel G. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat. Neurosci. 2009, 12:311-317.
4. Bendall L.J., Bradstock K.F. G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent. Cytokine Growth Factor Rev. 2014, 25:355-367.
5. Braun S., Kottwitz D., Nuber U.A. Pharmacological interference with the glucocorticoid system influences symptoms and lifespan in a mouse model of Rett syndrome. Hum. Mol. Genet. 2012, 21:1673-1680.
6. Butovsky O., Jedrychowski M.P., Moore C.S., Cialic R., Lanser A.J., Gabriely G., Koeglsperger T., Dake B., Wu P.M., Doykan C.E., et al. Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat. Neurosci. 2014, 17:131-143.
7. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 2007, 56:422-437.
8. Dai X.M., Ryan G.R., Hapel A.J., Dominguez M.G., Russell R.G., Kapp S., Sylvestre V., Stanley E.R. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002, 99:111-120.
9. Davies L.C., Jenkins S.J., Allen J.E., Taylor P.R. Tissue-resident macrophages. Nat. Immunol. 2013, 14:986-995.
10. Derecki N.C., Cronk J.C., Lu Z., Xu E., Abbott S.B., Guyenet P.G., Kipnis J. Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 2012, 484:105-109.
11. Dunn H.G., MacLeod P.M. Rett syndrome: review of biological abnormalities. Can. J. Neurol. Sci. 2001, 28:16-29.
12. Ebert D.H., Gabel H.W., Robinson N.D., Kastan N.R., Hu L.S., Cohen S., Navarro A.J., Lyst M.J., Ekiert R., Bird A.P., Greenberg M.E. Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature 2013, 499:341-345.
13. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M.F., Conway S.J., Ng L.G., Stanley E.R., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
14. Goldmann T., Wieghofer P., Müller P.F., Wolf Y., Varol D., Yona S., Brendecke S.M., Kierdorf K., Staszewski O., Datta M., et al. A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation. Nat. Neurosci. 2013, 16:1618-1626.
15. Gow D.J., Sester D.P., Hume D.A. CSF-1, IGF-1, and the control of postnatal growth and development. J.Leukoc. Biol. 2010, 88:475-481.
16. Guy J., Cheval H., Selfridge J., Bird A. The role of MeCP2 in the brain. Annu. Rev. Cell Dev. Biol. 2011, 27:631-652.
17. Hashimoto D., Chow A., Noizat C., Teo P., Beasley M.B., Leboeuf M., Becker C.D., See P., Price J., Lucas D., et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013, 38:792-804.
18. Jung S., Aliberti J., Graemmel P., Sunshine M.J., Kreutzberg G.W., Sher A., Littman D.R. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 2000, 20:4106-4114.
19. Khwaja O.S., Ho E., Barnes K.V., O'Leary H.M., Pereira L.M., Finkelstein Y., Nelson C.A., Vogel-Farley V., DeGregorio G., Holm I.A., et al. Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome. Proc. Natl. Acad. Sci. USA 2014, 111:4596-4601.
20. Kierdorf K., Erny D., Goldmann T., Sander V., Schulz C., Perdiguero E.G., Wieghofer P., Heinrich A., Riemke P., Hölscher C., et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 2013, 16:273-280.
21. Koelsch K.A., Webb R., Jeffries M., Dozmorov M.G., Frank M.B., Guthridge J.M., James J.A., Wren J.D., Sawalha A.H. Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human Tcells and a human MECP2 transgenic mouse. J.Autoimmun. 2013, 41:168-174.
22. Kozlowski C., Weimer R.M. An automated method to quantify microglia morphology and application to monitor activation state longitudinally invivo. PloS one 2012, 7:e31814.
23. Lioy D.T., Garg S.K., Monaghan C.E., Raber J., Foust K.D., Kaspar B.K., Hirrlinger P.G., Kirchhoff F., Bissonnette J.M., Ballas N., Mandel G. A role for glia in the progression of Rett's syndrome. Nature 2011, 475:497-500.
24. Litvak V., Ramsey S.A., Rust A.G., Zak D.E., Kennedy K.A., Lampano A.E., Nykter M., Shmulevich I., Aderem A. Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat. Immunol. 2009, 10:437-443.
25. Litvak V., Ratushny A.V., Lampano A.E., Schmitz F., Huang A.C., Raman A., Rust A.G., Bergthaler A., Aitchison J.D., Aderem A. A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature 2012, 490:421-425.
26. Lyst M.J., Ekiert R., Ebert D.H., Merusi C., Nowak J., Selfridge J., Guy J., Kastan N.R., Robinson N.D., de Lima Alves F., et al. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat. Neurosci. 2013, 16:898-902.
27. Maezawa I., Jin L.W. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J.Neurosci. 2010, 30:5346-5356.
28. McGraw C.M., Samaco R.C., Zoghbi H.Y. Adult neural function requires MeCP2. Science 2011, 333:186.
29. Nguyen M.V., Felice C.A., Du F., Covey M.V., Robinson J.K., Mandel G., Ballas N. Oligodendrocyte lineage cells contribute unique features to Rett syndrome neuropathology. The Journal of neuroscience: the official journal of the Society for Neuroscience 2013, 33:18764-18774.
30. Ning S., Pagano J.S., Barber G.N. IRF7: activation, regulation, modification and function. Genes Immun. 2011, 12:399-414.
31. Nuber U.A., Kriaucionis S., Roloff T.C., Guy J., Selfridge J., Steinhoff C., Schulz R., Lipkowitz B., Ropers H.H., Holmes M.C., Bird A. Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum. Mol. Genet. 2005, 14:2247-2256.
32. Schulz C., Gomez Perdiguero E., Chorro L., Szabo-Rogers H., Cagnard N., Kierdorf K., Prinz M., Wu B., Jacobsen S.E., Pollard J.W., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336:86-90.
33. Shahbazian M.D., Antalffy B., Armstrong D.L., Zoghbi H.Y. Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet. 2002, 11:115-124.
34. Sica A., Mantovani A. Macrophage plasticity and polarization: invivo veritas. J.Clin. Invest. 2012, 122:787-795.
35. Stellwagen D., Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 2006, 440:1054-1059.
36. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102:15545-15550.
37. Sunderkötter C., Nikolic T., Dillon M.J., Van Rooijen N., Stehling M., Drevets D.A., Leenen P.J. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J.Immunol. 2004, 172:4410-4417.
38. Tropea D., Giacometti E., Wilson N.R., Beard C., McCurry C., Fu D.D., Flannery R., Jaenisch R., Sur M. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc. Natl. Acad. Sci. USA 2009, 106:2029-2034.
39. Urdinguio R.G., Lopez-Serra L., Lopez-Nieva P., Alaminos M., Diaz-Uriarte R., Fernandez A.F., Esteller M. Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS ONE 2008, 3:e3669.
40. Varol C., Vallon-Eberhard A., Elinav E., Aychek T., Shapira Y., Luche H., Fehling H.J., Hardt W.D., Shakhar G., Jung S. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 2009, 31:502-512.
41. Wheeler M.A., Heffner D.L., Kim S., Espy S.M., Spano A.J., Cleland C.L., Deppmann C.D. TNF-α/TNFR1 signaling is required for the development and function of primary nociceptors. Neuron 2014, 82:587-602.
42. Yasui D.H., Xu H., Dunaway K.W., Lasalle J.M., Jin L.W., Maezawa I. MeCP2 modulates gene expression pathways in astrocytes. Mol Autism 2013, 4:3.
43. Yona S., Kim K.W., Wolf Y., Mildner A., Varol D., Breker M., Strauss-Ayali D., Viukov S., Guilliams M., Misharin A., et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013, 38:79-91.
44. Zigmond E., Jung S. Intestinal macrophages: well educated exceptions from the rule. Trends Immunol. 2013, 34:162-168.